Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

UiPath's share price has risen in recent months despite ongoing losses and slow growth. While market conditions are stable, there is still elevated deal scrutiny and longer sales cycles, particularly ...

UiPath Inc. raised its full-year revenue outlook after cruising past Wall Street’s expectations and swinging to a profit in its latest quarterly results, powered by momentum in its artificial ...

UiPath helps companies automate tasks traditionally performed by human employees with software robots. The slower-growth company might be the safer bet in this frothy market. Figma (NYSE: FIG) and ...

UiPath Inc. is putting meat on the bones of the plans it announced last October to enter the agentic artificial intelligence market with today’s rollout of what it calls a comprehensive platform for ...

UiPath is positioning itself as the bridge connecting humans, systems, and AI. The company has narrowed losses and is approaching profitability. The long-term growth runway is large. If you're looking ...

Agentic AI can simplify business, but managing disparate AI agents can also be a job in itself. UiPath’s platform helps businesses get their AI agents to work together. With the Maestro layer added to ...

UiPath offers an AI-driven automation platform, targeting workflow efficiency and accessibility for a broad range of users. PATH is undervalued, trading at a forward P/E of 22, an 11% discount to the ...

UiPath, Inc. (NYSE:PATH) shares are trading higher Tuesday after the company announced a partnership with OpenAI to develop ChatGPT to integrate OpenAI frontier models with enterprise customer ...